CPH 0.00% 0.9¢ creso pharma limited

2021 CPH Discussion, page-3

  1. 231 Posts.
    lightbulb Created with Sketch. 31
    “Creso Pharma is well funded to expand proprietary technologies into new verticals, with other value adding initiatives and revenue generating products in human and animal health under development – additional product launches expected shortly”
    ——-additional product launches tomorrow?
 
watchlist Created with Sketch. Add CPH (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.